Deoxyspergualin hydrochloride

盐酸胍立莫司

Report date: 2024/11/27 20:00:40
NME

Base Information

Drug NameDeoxyspergualin hydrochloride
Drug Alias Name胍立莫司GusperimusumGusperimus hydrochlorideSpanidinDSG +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines inhibitorsImmunosuppressants
TargetsCytokines
Therapy Area/IndicationsRejection of renal transplantationLupus NephritisGranulomatosis with Polyangiitis
Global Approved IndicationsRejection of renal transplantation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCzechiaSwedenNetherlands +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNippon Kayaku Co Ltd
Inactive CompaniesNordic Pharma Sas
Active IndicationsRejection of renal transplantation
Inactive IndicationsLupus NephritisGranulomatosis with Polyangiitis

Other Information

ATC CodeL04AA19
Related LinksWikipediaKEGG